-67.7%
ENPH vs SBAC
-9.5%
-58.2%
-81.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | -0.4% | +7.2% | +6.9% |
| 7D | +9.3% | -0.1% | +9.3% | +9.3% |
| 30D | -7.3% | +3.2% | -10.5% | -8.2% |
| 3M | -31.7% | -5.1% | -26.7% | -30.9% |
| 6M | -3.5% | -2.1% | -1.4% | -4.7% |
| YTD | +21.2% | -0.5% | +21.7% | +17.3% |
| 1Y | +0.1% | +1.1% | -1.1% | -4.4% |
| 3Y | -67.7% | -7.4% | -60.3% | -66.5% |
| All | -67.7% | -9.5% | -58.2% | -66.5% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling